Influence of repeated plaque visualization on cardiovascular risk reduction after 3 years: a randomized controlled

Kristyn Whitmore1,2,3, Zhen Zhou4, Jacqueline D M Ryan5

  • 1Baker Department of Cardiometabolic Health, The University of Melbourne, Grattan, Parkville, Victoria, 3010, Australia.

Insights

Visualizing coronary artery calcium (CAC) images in a nurse-led program significantly reduced cardiovascular risk scores and improved health markers. Repeated exposure to CAC images enhanced long-term risk control and lifestyle modifications.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Medical Imaging

Background:

  • Understanding cardiovascular (CV) risk is crucial for motivating risk reduction behaviors.
  • Coronary artery calcium (CAC) imaging provides personalized risk information.
  • The effectiveness of repeated CAC image visualization for sustained risk control was previously unclear.

Purpose of the Study:

  • To determine if repeated visualization of CAC images sustains long-term cardiovascular risk control in primary prevention.
  • To assess the impact of a nurse-led program combining CAC image visualization and statin therapy versus standard care.

Main Methods:

  • A randomized trial involving asymptomatic adults aged 40-70 with a family history of premature coronary artery disease and CAC scores (1-400).
  • Participants were randomized to a nurse-led CV risk reduction program with CAC image visualization and statin therapy or standard care.
  • The primary outcome was the change in Framingham Risk Score (FRS) at 36 months.

Main Results:

  • The intervention group showed a significantly greater reduction in FRS (difference in differences -3.4%) and LDL cholesterol compared to the control group.
  • Sustained recall of CAC images within the intervention group was associated with greater reductions in systolic blood pressure and waist circumference at 36 months.
  • The nurse-led program effectively initiated statin therapy in the intervention group.

Conclusions:

  • A nurse-led program incorporating personalized CAC image visualization and statin therapy is effective in improving cardiovascular risk.
  • Repeated visual exposure to CAC images may enhance risk reduction behaviors and outcomes.
  • CAC imaging visualization can be a valuable tool in primary prevention strategies.
Abstract

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...